FYERS
Home
/
Stocks
/
Results
/
Indo US Bio-Tech Results

Indo US Bio-Tech Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
19%22%21%6%
43%21%22%-19%
----45%
20%17%17%15%

Peer Comparison

Symbol
KSCL
VENKEYS
AVTNPL
BSHSL
FRESHARA-ST
REGAAL
MGEL
SHEETAL-SM
KOTYARK
NATHBIOGEN
INDOUS
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
730.2₹3716 Cr14.8954.460.16₹296 Cr
1,658.8₹2396 Cr13.8135.48149.6₹139 Cr
99.75₹1504 Cr17.952.046.26₹65 Cr
99₹1011 Cr35.221.362.89₹27 Cr
384₹939 Cr25.059.0716.89₹38 Cr
88.4₹921 Cr15.41.37.5₹56 Cr
17.1₹533 Cr11.290.261.51₹45 Cr
369₹429 Cr37.268.7212.2₹12 Cr
32.31₹364 Cr19.40.342.79₹19 Cr
136.8₹265 Cr7.2516.9821.37₹42 Cr
72₹151 Cr13.191.516.2₹13 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022
₹33 Cr₹26 Cr₹23 Cr₹31 Cr₹31 Cr₹33 Cr₹24 Cr₹22 Cr₹25 Cr₹16 Cr₹22 Cr₹16 Cr₹19 Cr₹18 Cr₹16 Cr₹14 Cr₹14 Cr
₹12 L₹2 L₹50,000₹3 L₹20,000₹12 L₹2 L₹2 L₹3 L₹21 L₹8 L₹30,000₹3 L₹2 L₹30,000₹0₹0
₹33 Cr₹26 Cr₹23 Cr₹31 Cr₹31 Cr₹34 Cr₹24 Cr₹22 Cr₹25 Cr₹16 Cr₹22 Cr₹16 Cr₹19 Cr₹18 Cr₹16 Cr₹14 Cr₹14 Cr
₹29 Cr₹23 Cr₹19 Cr₹27 Cr₹25 Cr₹29 Cr₹18 Cr₹17 Cr₹21 Cr₹15 Cr₹18 Cr₹13 Cr₹16 Cr₹15 Cr₹14 Cr₹12 Cr₹12 Cr
₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹5 Cr₹5 Cr₹6 Cr₹5 Cr₹4 Cr₹1 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr
₹74 L₹60 L₹77 L₹42 L₹45 L₹26 L₹38 L₹52 L₹33 L₹36 L₹37 L₹41 L₹37 L₹27 L₹41 L₹17 L₹29 L
₹3 Cr₹2 Cr₹3 Cr₹4 Cr₹5 Cr₹4 Cr₹5 Cr₹4 Cr₹3 Cr₹63 L₹4 Cr₹2 Cr₹2 Cr₹3 Cr₹1 Cr₹2 Cr₹2 Cr
₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹5 Cr₹4 Cr₹5 Cr₹4 Cr₹3 Cr₹52 L₹4 Cr₹2 Cr₹2 Cr₹3 Cr₹1 Cr₹1 Cr₹2 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
——————————————
₹20 Cr₹20 Cr₹20 Cr₹10 Cr₹9 Cr₹6 Cr₹6 Cr₹5 Cr₹3 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr
₹72 Cr₹58 Cr₹43 Cr₹44 Cr₹30 Cr₹15 Cr₹10 Cr₹9 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹91 L₹65 L
₹72 Cr₹58 Cr₹43 Cr₹44 Cr₹30 Cr₹15 Cr₹10 Cr₹9 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹91 L₹65 L
₹93 Cr₹79 Cr₹63 Cr₹54 Cr₹39 Cr₹22 Cr₹16 Cr₹14 Cr₹5 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr
₹56 L₹2 Cr₹2 Cr₹1 Cr₹3 Cr₹2 Cr₹5 L₹0₹0₹0₹0₹72,000₹2 L₹4 L
₹39 L₹1 Cr₹85 L₹29 L₹51 L₹1 Cr₹75 L₹66 L₹1 Cr₹46 L₹22 L₹46 L₹0₹0
-₹48 L-₹70 L-₹66 L-₹58 L-₹42 L-₹26 L₹7 L-₹87,912-₹30 L-₹44 L-₹60 L-₹48 L-₹24 L-₹9 L
₹0₹0₹1 Cr₹93 L₹1 Cr₹79 L₹60 L₹59 L₹41 L₹0₹0₹0₹0₹0
₹9 L₹5 L₹4 L₹4 L₹4 L₹3 L₹5 L₹4 L₹0₹0₹0₹0₹0₹0
₹56 L₹2 Cr₹4 Cr₹2 Cr₹4 Cr₹4 Cr₹2 Cr₹1 Cr₹1 Cr₹2 L-₹38 L-₹2 L-₹22 L-₹5 L
——————————————
₹45 L₹1 Cr₹4 Cr₹1 Cr₹2 Cr₹9 Cr₹8 Cr₹2 Cr₹5 Cr₹4 Cr₹5 Cr₹3 Cr₹2 Cr₹2 Cr
₹4 Cr₹5 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹1 Cr₹1 Cr₹46 L₹42 L₹47 L₹44 L₹59 L₹72 L
₹35 Cr₹10 Cr₹10 Cr₹8 Cr₹7 Cr₹7 Cr₹7 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹1 Cr₹2 Cr₹2 Cr
₹48 L₹30 L₹35 L₹10 L₹10 L₹8 L₹40 L₹61 L₹57 L₹20 L₹6 L₹11 L₹9 L₹7 L
₹40 Cr₹16 Cr₹17 Cr₹12 Cr₹12 Cr₹18 Cr₹17 Cr₹9 Cr₹10 Cr₹9 Cr₹10 Cr₹4 Cr₹4 Cr₹4 Cr
₹133 Cr₹97 Cr₹84 Cr₹69 Cr₹55 Cr₹43 Cr₹35 Cr₹24 Cr₹17 Cr₹12 Cr₹13 Cr₹7 Cr₹6 Cr₹6 Cr
₹3 Cr₹1 Cr₹98 L₹95 L₹67 L₹59 L₹0₹0₹0₹0₹5 L₹5 L₹5 L₹5 L
₹37 Cr₹15 Cr₹14 Cr₹12 Cr₹13 Cr₹11 Cr₹9 Cr₹6 Cr₹7 Cr₹5 Cr₹5 Cr₹2 Cr₹2 Cr₹2 Cr
——————————————
₹11 Cr₹15 Cr₹7 Cr₹7 Cr₹6 Cr₹2 Cr₹1 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr
₹0₹4 Cr₹0₹0₹0₹0₹0₹1 Cr₹0₹86 L₹83 L₹69 L₹58 L₹49 L
₹11 Cr₹10 Cr₹7 Cr₹7 Cr₹6 Cr₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹77 L
₹50 L₹0₹4 Cr₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹0₹0₹0₹0₹0₹0
₹0₹0₹0₹0₹99,000₹99,000₹0₹0₹0₹0₹0₹0₹0₹0
₹0₹0₹0₹0₹99,000₹99,000₹0₹0₹0₹0₹0₹0₹0₹0
₹21 L₹19 L₹24 L₹24 L₹23 L₹94 L₹8 L₹6 L₹2 L₹2 L₹2 L₹3 L₹3 L₹1 L
₹0₹0₹0₹0₹0₹0₹0₹0₹6 L₹0₹0₹0₹0₹0
₹12 Cr₹10 Cr₹11 Cr₹9 Cr₹8 Cr₹5 Cr₹3 Cr₹3 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹78 L
——————————————
₹100 Cr₹71 Cr₹52 Cr₹27 Cr₹23 Cr₹12 Cr₹9 Cr₹11 Cr₹6 Cr₹5 Cr₹5 Cr₹4 Cr₹2 Cr₹2 Cr
₹14 Cr₹15 Cr₹19 Cr₹25 Cr₹21 Cr₹25 Cr₹21 Cr₹9 Cr₹9 Cr₹5 Cr₹6 Cr₹1 Cr₹2 Cr₹3 Cr
₹6 Cr₹25 L₹1 Cr₹19 L₹5 L₹13 L₹20 L₹8 L₹7 L₹5 L₹10 L₹73,000₹47,000₹26,000
₹7 L₹4 L₹3 L₹2 L₹5 L₹5 L₹2 L₹2 L₹0₹0₹72,000₹0₹60,000₹1 L
₹79 L₹75 L₹1 Cr₹8 Cr₹3 Cr₹1 Cr₹2 Cr₹1 Cr₹88,252₹63 L₹97 L₹64 L₹67 L₹42 L
₹121 Cr₹87 Cr₹73 Cr₹60 Cr₹47 Cr₹38 Cr₹32 Cr₹21 Cr₹15 Cr₹11 Cr₹12 Cr₹6 Cr₹5 Cr₹5 Cr
₹81 Cr₹70 Cr₹56 Cr₹48 Cr₹35 Cr₹20 Cr₹15 Cr₹13 Cr₹5 Cr₹2 Cr₹2 Cr₹2 Cr₹83 L₹1 Cr
₹0₹0₹0₹0₹0₹1 L₹3 L₹4 L₹0₹0₹0₹0₹0₹0
₹133 Cr₹97 Cr₹84 Cr₹69 Cr₹55 Cr₹43 Cr₹35 Cr₹24 Cr₹17 Cr₹12 Cr₹13 Cr₹7 Cr₹6 Cr₹6 Cr
₹46₹39₹31₹54₹42₹35₹27₹29₹14₹23₹22₹19₹18₹15
₹46₹39₹31₹27₹21₹30₹23₹19₹10₹7₹6₹6₹5₹4

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
₹14 Cr₹17 Cr₹9 Cr₹7 Cr₹5 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr₹59 L₹24 L₹25 L₹11 L₹21 L
₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹70 L₹75 L₹26 L₹35 L₹44 L₹31 L₹30 L
-₹30 Cr-₹18 Cr-₹15 Cr-₹9 Cr-₹4 Cr-₹5 Cr-₹5 Cr-₹7 Cr-₹3 Cr-₹72 L-₹3 Cr-₹53 L₹9 L-₹1 Cr
-₹12 Cr₹2 Cr-₹4 Cr₹84 L₹3 Cr₹36 L-₹81 L-₹3 Cr-₹43 L₹14 L-₹3 Cr₹17 L₹50 L-₹59 L
-₹13 Cr₹1 Cr-₹5 Cr₹53 L₹3 Cr₹22 L-₹84 L-₹3 Cr-₹88 L₹7 L-₹3 Cr₹14 L₹46 L-₹63 L
-₹2 Cr-₹79 L₹4 Cr-₹7 Cr-₹5 Cr-₹2 Cr-₹57 L-₹3 Cr₹31 L-₹17 L-₹11 L-₹17 L-₹21 L-₹36 L
₹20 Cr-₹1 Cr₹1 Cr₹6 Cr₹2 Cr₹1 Cr₹2 Cr₹6 Cr₹59 L₹5 L₹3 Cr₹3 L-₹25 L₹99 L
₹6 Cr-₹85 L₹91 L₹14 L-₹8 L-₹7 L₹12 L₹1 L₹2 L-₹5 L₹10 L₹26,000₹21,000-₹13,000
₹25 L₹1 Cr₹19 L₹5 L₹13 L₹20 L₹8 L₹7 L₹5 L₹10 L₹72,000₹47,000₹26,000₹39,000
₹6 Cr₹25 L₹1 Cr₹19 L₹5 L₹13 L₹20 L₹8 L₹7 L₹5 L₹10 L₹73,000₹47,000₹26,000

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)72.99
Volume (₹)3,115.00
High (₹)75.90
Upper Circuit86.42
Low (₹)71.60
Lower Circuit57.62
Prev Close72.02
52W High (₹)159.00
Price72.00
52W Low (₹)70.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)151.05 Cr
Div. Yield (%)0.00
PE Ratio13.19
Debt to Equity0.40
Price to Book2.12
Book Value46.15
EPS (TTM)5.71
Face Value10.00
ROE (%)15.34

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
KSCLNSE
VENKEYSNSE
AVTNPLNSE
BSHSLNSE
FRESHARA-STNSE
REGAALNSE
MGELNSE
SHEETAL-SMNSE
KOTYARKNSE
NATHBIOGENNSE
INDOUSNSE
LTP
1W Low
1W High
Market cap (₹)
730.2+53.4 (7.89%)
676.35
735.45
3,716Cr
1658.8+63 (3.95%)
1571
1739.40
2,396Cr
99.75+4.97 (5.24%)
93.29
105.33
1,504Cr
99+15.42 (18.45%)
83.12
103
1,011Cr
384-17.4 (-4.33%)
380
407
939Cr
88.4+4.31 (5.13%)
83.25
92.09
921Cr
17.1+1.29 (8.16%)
15.52
17.20
533Cr
369+25.5 (7.42%)
346
370
429Cr
32.31+0.03 (0.09%)
31.40
35.75
364Cr
136.8-0.99 (-0.72%)
134.20
143.54
265Cr
72-1.96 (-2.65%)
70.25
75.90
151Cr

Indo US Bio-Tech Ltd Annual Results Key Takeaways

Basis: Consolidated annual results.

Indo US Bio-Tech Ltd Quaterly Results Key Takeaways